Identification and Management of Immune Checkpoint Inhibitor-Related Myocarditis: Use Troponin Wisely

J Clin Oncol. 2019 Sep 1;37(25):2201-2205. doi: 10.1200/JCO.18.02464. Epub 2019 May 14.

Authors

Paolo Spallarossa¹, Giacomo Tini^{1

2}, Matteo Sarocchi^{1

2}, Eleonora Arboscello¹, Francesco Grossi³, Paola Queirolo¹, Gabriele Zoppoli^{1

2}, Pietro Ameri^{1

2}

Affiliations

¹ Istituto di Ricovero e Cura a Carattere Scientifico Ospedale Policlinico San Martino, Genoa, Italy.
² University of Genova, Genoa, Italy.
³ Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

PMID: 31084547
DOI: 10.1200/JCO.18.02464

No abstract available

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects*
Antineoplastic Agents, Immunological / adverse effects*
Databases, Factual
Humans
Myocarditis / chemically induced*
Myocarditis / diagnosis*
Myocarditis / immunology
Myocarditis / metabolism
Troponin I / analysis
Troponin I / metabolism*
Troponin T / analysis
Troponin T / metabolism*

Substances

Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
Troponin I
Troponin T